Professor Shankar Balasubramanian knighted
Congratulations to Professor Shankar Balasubramanian who has been named a Knight Bachelor for services to science and medicine.
He co-invented next generation sequencing which has provided one of the most transformative changes in biology and medicine for several decades, and has led to the $1000 dollar human genome. He has also made important contributions to four-stranded DNA, known as G-quadruplexes, and their role in cancer. Professor Balasubramanian is Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College.
It is a great honour for me and a wonderful acknowledgement of the research that I have carried out in Cambridge with my co-workers and collaborators over the past two decades. I was particularly pleased to see recognition of our basic science and its impact on medicine, as I am jointly appointed between the Departments of Chemistry and Medicine.
– Professor Sir Shankar Balasubramanian, Cancer Research UK Cambridge Institute
Related News
See all news-
Dr Guiping Wang appointed as a Junior Group Leader
18th May 2026
Dr Guiping Wang joins the Cancer Research UK Cambridge Institute as a Junior Group Leader, starting in September 2026.
Find out more -
Shankar Balasubramanian receives the Princess of Asturias Award for Scientific and Technical Research
14th May 2026
The 2026 award recognises Prof Balasubramanian and his co-recipients David Klenerman and Pascal Meyer for their pioneering work in genome sequencing technologies.
Find out more -
Prof Sir Steve Jackson receives the 2026 Galen Medal in Therapeutics
14th May 2026
This award comes in recognition of his transformational work on the mechanisms of DNA repair, cell survival and the DNA-damage response (DDR), as well as for the development of the cancer-targeting drug Olaparib.
Find out more